This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

BOOK NOW
Menu
BOOK NOW

Aaron Sato, PhD
Chief Strategy Officer at Adimab
Speaker

Profile

Aaron is the Chief Strategy Officer at Adimab, with over 25 years of experience in biotechnology, focusing on discovering and developing novel first-in-class antibody therapeutics. Before joining Adimab, Aaron served as the Chief Scientific Officer of Twist Bioscience, where he led their Biopharma Solutions business. Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center. He is the author of over 40 peer-reviewed papers and 70 issued patents in the antibody space.

At this event

Prev
Next
Takashi Sato, PhD
Chief Scientist & Technical Architect, Life Science Product Division
Rigaku Corporation

See Aaron at Antibody Engineering & Therapeutics Asia

BOOK NOW